Assay and clinical significance of serum tumor markers in diagnosis of pancreatic carcinoma
- VernacularTitle:胰腺癌患者血清肿瘤标志物的检测及其临床意义
- Author:
Lizhong ZHANG
;
Zhi ZHAO
;
Bin WU
- Publication Type:Journal Article
- Keywords:
Pancreatic neoplasms;
Tumor markers,biology
- From:
Cancer Research and Clinic
2008;20(11):754-756
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the expression of serum tumor markers in pancreatic carcinoma and to assess the value of serum tumor markers in the diagnosis and prognosis of pancreatic carcinoma. Methods Five serum tumor markers including AFP, CEA, CA199, CA125 and CA242 were detected in 95 patients with pancreatic carcinoma by chemi-luminescence immunoassay (CLI) and enzyme linked immunosorbent assay (ELISA), 80 patients with other malignant tumor and 65 patients with benign disease served as controls. Five tumor markers in pancreatic carcinoma diagnosis for TNM staging were compared. The value of tumor markers for prognosis was analyzed. Results Among these 5 kinds of tumor marker, CA199, CAI25, CA242 were valuable in diagnosis of pancreatic carcinoma, and CA199 was the most valuable one, whose sensitivity and specificity were 76.2 % and 74.8 % respectively. CA199, CA125, CA242 were increased with progression of pancreatic carcinoma. Conclusion Serum CA199, CA125 and CA242 are the preferred tumor markers to be used in the diagnosis and prognosis of pancreatic carcinoma.
